Tevogen Bio Holdings Inc. Cash Flow-to-Debt Ratio
Tevogen Bio Holdings Inc. cash flow-to-debt ratio. Tevogen Bio Holdings Inc. (TVGN) has a Cash Flow-to-Debt Ratio of -0.22x as of June 2026, meaning its operating cash flow of $-3.01 Million could theoretically repay 0% of its total liabilities ($13.62 Million) in one year. Check TVGN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tevogen Bio Holdings Inc. (2022–2026)
Cash flow-to-debt ratio of Tevogen Bio Holdings Inc. from 2022 to 2026. Historical debt coverage capacity for Tevogen Bio Holdings Inc. across 5 annual periods. Also explore Tevogen Bio Holdings Inc. (TVGN) net asset momentum to track the company's year-over-year net asset growth rate.
Tevogen Bio Holdings Inc. Cash Flow-to-Debt Ratio by Year (2022–2026)
Tevogen Bio Holdings Inc. cash flow-to-debt ratio by year from 2022 to 2026. Year-by-year debt coverage analysis for Tevogen Bio Holdings Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Tevogen Bio Holdings Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.98x | $-12.33 Million | $12.62 Million | ▲ +17.5% |
| 2025 | -1.18x | $-12.00 Million | $10.14 Million | ▼ -1347.8% |
| 2024 | -0.08x | $-8.17 Million | $99.93 Million | ▲ +60.6% |
| 2023 | -0.21x | $-8.66 Million | $41.69 Million | ▲ +5.0% |
| 2022 | -0.22x | $-5.27 Million | $24.15 Million | — |